JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2013, Vol. 51 ›› Issue (7): 1-5.

• Articles •     Next Articles

Protective effects of rhEPO on oxidative stress damage in cardiomyocytes and on heart after myocardial infarction

WANG Fu1, LIU Shan-wen1, LI Bin2, GENG Hai-hua3, SUN Shuai1, LI Rui1, XIAO Jie1, JI Xiao-ping1   

  1. 1.Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China;
    2. Department of Health, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China;
    3. Department of Cardiology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China
  • Received:2012-11-15 Online:2013-07-10 Published:2013-07-10

Abstract:

Objective   To study the protective effects of recombinant human erythropoietin(rhEPO)on cardiomyocytes against oxidative damage and on mice hearts after myocardial infarction. Methods   Isolated neonatal rat cardiomyocytes were treated with rhEPO in vitro after the establishment of oxidative damage experimental models. Thiazolyl blue (MTT) assay and flow cytometry (FCM) were used to detect the apoptosis rate of cardiomyocytes. Protein expression levels of caspase-3, Bax and Bcl-2 were detected by Western blotting. Mice were randomly divided into the sham group, the myocardial infarction group and the rhEPO treatment group. Myocardial infarction models were induced by the ligation of the left anterior descending artery in mice. Mouse heart was harvested after 14 days. HE staining was used to investigate the effects of rhEPO on the myocardial infarct size. Results   In the process of oxidative damage, rhEPO could significantly reduce the apoptosis rate of cardiomyocytes and the expressions of caspase-3 and Bax, but could raise the expression of Bcl-2. HE staining showed that rhEPO could significantly reduce the myocardial infarct size of mouse heart. Conclusion   RhEPO can protect cardiomyocytes from oxidative stress damage induced by H2O2 and reduce the myocardial infarct size in mice after myocardial infarction.

Key words: Recombinant human erythropoietin; Cardiomyocytes; Oxidative stress damage; Myocardial infarction

CLC Number: 

  • R542.2
[1] SHEN Xiao-qian1, ZHANG Wen-dong2, HE Yuan-liu3, CONG Xiao4, SU Guo-hai4, HAO En-kui1. Research on cardiac dysfunction induced by trastuzumab and the possible mechanisms [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 11-14.
[2] KAN Li-li1, JIANG Fang-guo1, AN Feng-shuang2. Effect and expression of GRK2 on collagen synthesis in myocardial fibrosis rat model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 22-25.
[3] SUO Fei1, HU He-sheng2, XUE Mei2, WANG Ye1, XUAN Yong-li1, YAN Su-hua2 . Relationship between neurturin dynamic expression after myocardial infarction and cardiac vagal neural remodeling [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 1-5.
[4] ZHAO Li-xiang, WU Xin-ning, WANG Xi, LI Na, CHEN Tong-shuai, LIU Jun-ni, BU Pei-li. Effects of NAD on the mRNA expression of collagen  type I induced by Angiotensin II in cardiac fibroblasts [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 1-5.
[5] LU Guan-yan1, CUI Bin2, LIU Zhong-liang3, LI Yu-tang4, LIU Xue-fei3, MA Xiao-jing1, ZHU Gui-yue1, YUAN Hai-tao1. Valsartan alters the balance of Th17 cells to regulatory T cells in chronic viral  myocarditis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 1-.
[6] WANG Qi-lei1, REN Man-yi2, WANG De-jin1, XU Dong-ling1, DU Yi-meng1, WANG Xu-ping3, SUI Shu-jian1. TWEAK promotes expressions of collagen I and matrix metalloproteinase1
in rat cardiac fibroblasts via P38MAPK pathway
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(11): 43-47.
[7] WANG De-jin1, REN Man-yi2, CHEN Hui-na1, WANG Xu-ping3, SUI Shu-jian1. Tumor necrosis factor-like weak inducer of apoptosis promotes expression of matrix metalloproteinase 9 in rat cardiac fibroblasts via the nuclear factor-κB pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 13-17.
[8] KAN Li-li1,2, AN Feng-shuang2. Evaluation of E/E′ on left ventricular diastolic function affected by  drug-treatment in the patients with hypertrophic cardiomyopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 105-108.
[9] MA Li-na1, YAO Min-qiang2, WANG Pei-xian1. Echocardiographic evaluation on cardiac structure and function in patients with symptomatic alcoholic cardiomyopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 82-85.
[10] . Prevalence of Fabry disease in patients with  hypertrophic cardiomyopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(3): 116-119.
[11] . Quantitative analysis of cardiac troponin T and the risk factors of myocardial infarction [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(11): 114-117.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!